1. Bock, K. W., Forster, A., Gschaidmeier, H., Bruck, M., Munzel, P., Schareck, W., Fournel-Gigleux, S., and Burchell B. (1993). Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem. Pharmacol.45,1809–1814.
2. Bray, G. P., Harrison, P. M., O'Grady, J. G., Tredger, M. J., and Williams, R. (1992). Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum. Exp. Toxicol.11,265–270.
3. Court, M., Duan, S., Moltke, L., Greenblatt, D., Patten, J., Miners, J., and Mackenzie, P. (2001). Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoform. J. Pharmacol. Exp. Ther.299,998–1006.
4. Court, M., and Greenblatt, J. (1997). Biochemical basis for deficient paracetamol glucuronidation in cats: An interspecies comparison of enzyme constraint in liver microsomes. J. Pharm. Pharmacol.48,446–449.
5. Cummings, J., Ethell, B. T., Jardine, L., Boyd, G., Macpherson, J., and Burchell, B. (2003). Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: Reversal of resistance by food additives. Cancer Res.63,8443–8450.